Time has a way of validating or refuting one's assertions. Ariad has never been a garbage stock despite the mistakes that led to the 2013 crash. After almost 3 years we are seeing how important good management can be and over the next few years we may well see Ariad exceed its former valuation if it isnt acquired earlier. Next up is the Japan approval for Ponatinib. The future looks brighter now for this company than at any point in its history. Thank God Denner came on board.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.